Position in CLRB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,596
-$15,905 QoQ
Shares Held
3,093
-67.9% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 29 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CLRB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. CLRB ranks #455 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in CLRB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,596 | 3,093 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $24,501 | 9,647 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $7,663 | 2,598 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $5,083 | 908 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $25,736 | 3,620 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $294,510 | 920,352 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $112,857 | 376,199 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,513 | 2,577 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $36,998 | 14,800 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $23,679 | 5,950 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,323 | 1,200 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,314 | 1,256 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $2,339 | 1,200 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,016 | 2,110 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,821 | 1,650 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $5,543 | 1,650 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $15,855 | 39,642 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $11,384 | 16,500 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $34,291 | 51,958 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,694 | 11,500 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,684 | 11,500 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,219 | 2,000 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,047 | 1,465 | Shares | Sole | 2021-02-11 | |
| 2020-06-30 | $1,465 | 1,145 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $801 | 603 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||